Capital Research Global Investors (JBS) discloses 4.4% beneficial stake in JBS N.V.

Rhea-AI Filing Summary

Capital Research Global Investors, a division of Capital Research and Management Company and affiliated investment management entities, reported beneficial ownership of 34,441,673 shares of JBS N.V. common stock, representing 4.4% of the 776,086,920 shares believed to be outstanding. The filing states sole voting power over 34,302,052 shares and sole dispositive power over all 34,441,673 shares, with no shared voting or dispositive power. The position includes 34,302,014 Depository Receipts, each representing one share of common stock. The report is filed on Schedule 13G/A, indicating ownership of 5 percent or less of the class.

Key Figures

Beneficial ownership: 34,441,673 shares Percent of class: 4.4% Shares outstanding baseline: 776,086,920 shares +3 more

6 metrics

Beneficial ownership 34,441,673 shares Shares of JBS N.V. common stock deemed beneficially owned by Capital Research Global Investors

Percent of class 4.4% Percentage of JBS N.V. common stock outstanding represented by Capital Research Global Investors’ holdings

Shares outstanding baseline 776,086,920 shares JBS N.V. shares believed to be outstanding used to calculate percent of class

Sole Voting Power 34,302,052 shares Number of JBS N.V. shares over which Capital Research Global Investors has sole voting power

Sole Dispositive Power 34,441,673 shares Number of JBS N.V. shares over which Capital Research Global Investors has sole dispositive power

Depository Receipts held 34,302,014 Depository Receipts included in the reported JBS N.V. holdings, each representing one common share

Key Terms

beneficial owner, Depository Receipts, Sole Voting Power, Sole Dispositive Power, +1 more

5 terms

beneficial owner financial

"CRGI is deemed to be the beneficial owner of 34,441,673 shares"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

Depository Receipts financial

"Shares reported include 34,302,014 Depository Receipts, which represent 34,302,014 Common Stock"

A depository receipt is a tradable certificate issued by a bank that represents ownership of shares held in a foreign company, letting investors buy and sell those shares on their local stock market without dealing with the foreign exchange and custody details. Think of it as a local receipt for a piece of a foreign company kept in a secure vault abroad; it matters because it makes international investing easier, often increases liquidity, and can affect dividend payments and currency risk.

Sole Voting Power financial

"Sole Voting Power 34,302,052.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole Dispositive Power 34,441,673.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13G regulatory

"CRGI is deemed to be the beneficial owner of 34,441,673 shares or 4.4% of the 776,086,920 shares believed to be outstanding."

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of JBS (JBS) does Capital Research Global Investors currently own?

Capital Research Global Investors reported beneficial ownership of 4.4% of JBS N.V.’s common stock, corresponding to 34,441,673 shares out of 776,086,920 shares believed to be outstanding, according to the Schedule 13G/A filing.

How many JBS (JBS) shares are beneficially owned by Capital Research Global Investors?

Capital Research Global Investors is deemed the beneficial owner of 34,441,673 JBS N.V. common shares. This total includes 34,302,014 Depository Receipts, each representing one share, and reflects both its direct and affiliated investment management entities’ holdings.

What voting power does Capital Research Global Investors report over JBS (JBS) shares?

Capital Research Global Investors reports sole voting power over 34,302,052 JBS N.V. shares and no shared voting power. It also reports sole dispositive power over 34,441,673 shares, indicating exclusive authority to decide how those shares are voted and disposed.

Why did Capital Research Global Investors file a Schedule 13G/A for JBS (JBS)?

Capital Research Global Investors filed a Schedule 13G/A to report beneficial ownership of 4.4% of JBS N.V.’s common stock, which is 5 percent or less of the class. The amendment updates its ownership position and associated voting and dispositive powers.

How many JBS (JBS) shares are outstanding according to Capital Research Global Investors?

Capital Research Global Investors states that its 4.4% stake represents ownership relative to 776,086,920 JBS N.V. shares believed to be outstanding. This outstanding share figure is used to calculate the reported percentage of class in the Schedule 13G/A.

What is the role of Depository Receipts in Capital Research’s JBS (JBS) position?

The reported JBS N.V. position includes 34,302,014 Depository Receipts, each representing one common share. These Depository Receipts form nearly all of Capital Research Global Investors’ 34,441,673-share beneficial ownership stake disclosed in the Schedule 13G/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 05:08 PM Accepted by SEC EDGAR 08/12/2026 - 05:08 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

JBS N.V.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

N4732M103

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): N4732M103

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 34,302,052.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 34,441,673.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

34,441,673.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.4 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: JBS N.V.
(b)	Address of issuer's principal executive offices: STROOMBAAN 16, 5E VERDIEPING, Amstelveen 1181 VX, Netherlands
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: N4732M103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 34,441,673 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 34,441,673 shares or 4.4% of the 776,086,920 shares believed to be outstanding. Shares reported include 34,302,014 Depository Receipts, which represent 34,302,014 Common Stock.
(b)	Percent of class: 4.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 34,302,052
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 34,441,673
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Senior Vice President and Associate General Counsel, Capital Research and Management Company
Date:	08/11/2026